CRVS
Corvus Pharmaceuticals Inc
NASDAQ: CRVS · HEALTHCARE · BIOTECHNOLOGY
$11.62
-1.53% today
Updated 2026-09-25
Market cap
$977.49M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.63
Dividend yield
—
52W range
$6 – $27
Volume
0.9M
Corvus Pharmaceuticals Inc (CRVS) Insider transactions
Net insider activity
Net buying (11,148,444 shares)
Buy transactions
91
Sell transactions
9
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-11 | VAN, DEN BROEK RICHARD | Director | Buy | 15,000 | — | — |
| 2026-06-11 | THOMPSON, PETER A. | Director, 10% Owner | Buy | 15,000 | — | — |
| 2026-06-11 | MOORE, DAVID SCOTT | Director | Buy | 15,000 | — | — |
| 2026-06-11 | MOORE, DAVID SCOTT | Director | Buy | 21,700 | $11.53 | $250235.72 |
| 2026-06-11 | GRAIS, LINDA | Director | Buy | 15,000 | — | — |
| 2026-06-11 | CLARK, IAN T | Director | Buy | 15,000 | — | — |
| 2026-05-18 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 5,000 | $12.05 | $60250.00 |
| 2026-05-18 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 1,932 | $12.01 | $23203.32 |
| 2026-04-23 | CHAN, ANDREW C. | Director | Buy | 30,000 | — | — |
| 2026-01-28 | THOMPSON, PETER A. | Director, 10% Owner | Sale | 30,000 | — | — |
| 2026-01-28 | THOMPSON, PETER A. | Director, 10% Owner | Sale | 15,000 | — | — |
| 2026-01-28 | THOMPSON, PETER A. | Director, 10% Owner | Buy | 30,000 | $15.00 | $450000.00 |
| 2026-01-28 | THOMPSON, PETER A. | Director, 10% Owner | Buy | 15,000 | $2.12 | $31800.00 |
| 2025-12-04 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 1,000,000 | — | — |
| 2025-12-04 | LEA, LEIV | Chief Financial Officer | Buy | 400,000 | — | — |
| 2025-12-04 | JONES, WILLIAM BENTON | See Remarks | Buy | 400,000 | — | — |
| 2025-12-04 | ARCARA, JEFFREY | Chief Business Officer | Buy | 100,000 | — | — |
| 2025-10-02 | MOORE, DAVID SCOTT | Director | Buy | 30,000 | — | — |
| 2025-06-27 | THOMPSON, PETER A. | Director, 10% Owner | Sale | 1,397,684 | — | — |
| 2025-06-27 | THOMPSON, PETER A. | Director, 10% Owner | Buy | 1,397,684 | $3.50 | $4.89M |
| 2025-06-27 | THOMPSON, PETER A. | Director, 10% Owner | Sale | 1,176,332 | $4.16 | $4.89M |
| 2025-06-27 | ORBIMED, ADVISORS LLC | Director, 10% Owner | Sale | 1,397,684 | — | — |
| 2025-06-27 | ORBIMED, ADVISORS LLC | Director, 10% Owner | Buy | 1,397,684 | $3.50 | $4.89M |
| 2025-06-27 | ORBIMED, ADVISORS LLC | Director, 10% Owner | Sale | 1,176,332 | $4.16 | $4.89M |
| 2025-06-12 | THOMPSON, PETER A. | Director, 10% Owner | Buy | 15,000 | — | — |
| 2025-06-12 | MORRISON, SCOTT W | Director | Buy | 15,000 | — | — |
| 2025-06-12 | GRAIS, LINDA | Director | Buy | 15,000 | — | — |
| 2025-06-12 | CLARK, IAN T | Director | Buy | 15,000 | — | — |
| 2025-06-04 | JONES, WILLIAM BENTON | See Remarks | Sale | 19,357 | — | — |
| 2025-06-04 | JONES, WILLIAM BENTON | See Remarks | Buy | 19,357 | $3.50 | $67749.50 |
| 2025-05-07 | MILLER, RICHARD A MD | Director, President and CEO | Sale | 559,073 | — | — |
| 2025-05-07 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 559,073 | $3.50 | $1.96M |
| 2025-04-08 | VAN, DEN BROEK RICHARD | Director | Buy | 30,000 | — | — |
| 2024-12-20 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 750,000 | — | — |
| 2024-12-20 | LEA, LEIV | Chief Financial Officer | Buy | 300,000 | — | — |
| 2024-12-20 | JONES, WILLIAM BENTON | See Remarks | Buy | 300,000 | — | — |
| 2024-12-20 | ARCARA, JEFFREY | Chief Business Officer | Buy | 50,000 | — | — |
| 2024-06-13 | THOMPSON, PETER A. | Director, 10% Owner | Buy | 15,000 | — | — |
| 2024-06-13 | MORRISON, SCOTT W | Director | Buy | 15,000 | — | — |
| 2024-06-13 | GRAIS, LINDA | Director | Buy | 15,000 | — | — |
| 2024-06-13 | GOULD, TERRY P | Director, 10% Owner | Buy | 15,000 | — | — |
| 2024-06-13 | CLARK, IAN T | Director | Buy | 15,000 | — | — |
| 2024-05-10 | MILLER, RICHARD A MD | Director, President and CEO | Sale | 302,016 | — | — |
| 2024-05-06 | THOMPSON, PETER A. | Director, 10% Owner | Buy | 1,444,085 | $1.73 | $2.50M |
| 2024-05-06 | THOMPSON, PETER A. | Director, 10% Owner | Buy | 1,397,684 | — | — |
| 2024-05-06 | ORBIMED, ADVISORS LLC | Director, 10% Owner | Buy | 1,444,085 | $1.73 | $2.50M |
| 2024-05-06 | ORBIMED, ADVISORS LLC | Director, 10% Owner | Buy | 1,397,684 | — | — |
| 2024-05-06 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 559,073 | — | — |
| 2024-05-06 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 577,634 | $1.73 | $999999.98 |
| 2024-05-06 | JONES, WILLIAM BENTON | See Remarks | Buy | 19,357 | — | — |
| 2024-05-06 | JONES, WILLIAM BENTON | See Remarks | Buy | 20,000 | $1.73 | $34624.00 |
| 2024-02-28 | ARCARA, JEFFREY | Chief Business Officer | Buy | 400,000 | — | — |
| 2023-12-06 | THOMPSON, PETER A. | Director, 10% Owner | Buy | 15,000 | — | — |
| 2023-12-06 | MORRISON, SCOTT W | Director | Buy | 15,000 | — | — |
| 2023-12-06 | MITCHELL, EDITH P. | Director | Buy | 15,000 | — | — |
| 2023-12-06 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 500,000 | — | — |
| 2023-12-06 | LEA, LEIV | Chief Financial Officer | Buy | 200,000 | — | — |
| 2023-12-06 | JONES, WILLIAM BENTON | See Remarks | Buy | 200,000 | — | — |
| 2023-12-06 | GRAIS, LINDA | Director | Buy | 15,000 | — | — |
| 2023-12-06 | GOULD, TERRY P | Director, 10% Owner | Buy | 15,000 | — | — |
| 2023-12-06 | CLARK, IAN T | Director | Buy | 15,000 | — | — |
| 2023-06-15 | THOMPSON, PETER A. | Director, 10% Owner | Buy | 15,000 | — | — |
| 2023-06-15 | MORRISON, SCOTT W | Director | Buy | 15,000 | — | — |
| 2023-06-15 | MITCHELL, EDITH P. | Director | Buy | 15,000 | — | — |
| 2023-06-15 | GRAIS, LINDA | Director | Buy | 15,000 | — | — |
| 2023-06-15 | GOULD, TERRY P | Director, 10% Owner | Buy | 15,000 | — | — |
| 2023-06-15 | CLARK, IAN T | Director | Buy | 15,000 | — | — |
| 2023-05-15 | GRAIS, LINDA | Director | Buy | 10,000 | $2.45 | $24500.00 |
| 2023-03-31 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 800,000 | — | — |
| 2022-12-20 | JONES, WILLIAM BENTON | See Remarks | Buy | 20,000 | $0.79 | $15800.00 |
| 2022-12-14 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 10,000 | $0.78 | $7812.00 |
| 2022-12-14 | LEA, LEIV | Chief Financial Officer | Buy | 4,000 | $0.84 | $3364.00 |
| 2022-12-13 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 50,000 | $0.74 | $37015.00 |
| 2022-12-13 | LEA, LEIV | Chief Financial Officer | Buy | 30,000 | $0.74 | $22275.00 |
| 2022-09-28 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 25,000 | $0.76 | $19070.00 |
| 2022-09-20 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 12,300 | $0.81 | $9964.23 |
| 2022-09-20 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 5,000 | $0.82 | $4075.00 |
| 2022-09-20 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 2,700 | $0.82 | $2214.00 |
| 2022-08-11 | THOMPSON, PETER A. | Director, 10% Owner | Buy | 15,000 | — | — |
| 2022-08-11 | MORRISON, SCOTT W | Director | Buy | 15,000 | — | — |
| 2022-08-11 | MITCHELL, EDITH P. | Director | Buy | 15,000 | — | — |
| 2022-08-11 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 320,000 | — | — |
| 2022-08-11 | LEA, LEIV | Chief Financial Officer | Buy | 160,000 | — | — |
| 2022-08-11 | JONES, WILLIAM BENTON | See Remarks | Buy | 160,000 | — | — |
| 2022-08-11 | GRAIS, LINDA | Director | Buy | 15,000 | — | — |
| 2022-08-11 | GOULD, TERRY P | Director, 10% Owner | Buy | 15,000 | — | — |
| 2022-08-11 | CLARK, IAN T | Director | Buy | 15,000 | — | — |
| 2022-08-11 | ADAMS, STREET PARTNERS LLC | 10% Owner | Buy | 15,000 | — | — |
| 2022-06-27 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 5,000 | $1.00 | $4984.50 |
| 2022-06-24 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 5,000 | $1.03 | $5150.00 |
| 2022-06-15 | THOMPSON, PETER A. | Director, 10% Owner | Buy | 15,000 | — | — |
| 2022-06-15 | MORRISON, SCOTT W | Director | Buy | 15,000 | — | — |
| 2022-06-15 | MITCHELL, EDITH P. | Director | Buy | 15,000 | — | — |
| 2022-06-15 | GRAIS, LINDA | Director | Buy | 15,000 | — | — |
| 2022-06-15 | GOULD, TERRY P | Director, 10% Owner | Buy | 15,000 | — | — |
| 2022-06-15 | CLARK, IAN T | Director | Buy | 15,000 | — | — |
| 2022-06-06 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 890 | $1.01 | $898.90 |
| 2022-06-02 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 4,830 | $0.98 | $4733.40 |
| 2022-06-02 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 170 | $0.97 | $164.90 |
| 2022-03-31 | MILLER, RICHARD A MD | Director, President and CEO | Buy | 15,000 | $1.64 | $24534.00 |
Frequently asked questions
Are CRVS insiders buying or selling?
Over the transactions on record, CRVS insiders have been net buyers, with about $9.78M in stock sold across 9 sales, against 29 open-market purchases.
Does insider selling at CRVS mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which CRVS insiders are selling the most?
Recent selling is concentrated in a few names. THOMPSON, PETER A. accounts for the largest share on record, with about $4.89M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.